Pancreatic cancer is deadly and difficult to treat. A new pill could change that - PBS
Hannah Grabenstein Hannah Grabenstein A new drug that targets a gene behind pancreatic cancer has physicians and researchers cautiously optimistic about improved treatment for one of the deadliest cancers. Revolution Medicines, the pharmaceutical company behind the new drug, will release more in-depth data Sunday on the clinical trial testing of its pill.
Waymo’s newest robotaxi is Chinese-made, built to make money, and now accepting riders - TechCrunch
Waymo has started giving select riders in Los Angeles, Phoenix, and San Francisco access to its newest robotaxi: an all-electric, minivan-like vehicle that is designed to lower costs and handle the use and abuse of hundreds of thousands of riders. Waymo said Thursday it will eventually expand access to the vehicle, a modified Zeekr-made minivan called the Ojai (pronounced oh-hi), to more riders and cities.
We’re living in the ‘premium economy’ economy - CNN
The biggest economic buzzword of the last few years is “K-shaped.” CEOs, economists and lawmakers all use the letter K to describe the divergence between the haves and have-nots in America’s economy, from the housing market to spending on gas. The wealthiest people in America have split from the poorest.
Sun Pharma, Coforge: Indian businesses go shopping abroad as growth slows at home - BBC
ShareSaveAdd as preferred on GoogleNikhil InamdarMumbaiBloomberg via Getty ImagesIndia's Sun Pharmaceuticals paid $11.75bn to buy New York-listed Organon & CoIn late April, India's Sun Pharmaceuticals agreed to pay $11.75bn (£8.59bn) to acquire New York-listed women's health and biosimilars firm Organon & Co. It marked the biggest overseas acquisition by an Indian company in nearly two decades and followed a string of high-profile international deals by Indian firms in recent months.